Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls

被引:89
作者
Ankarberg-Lindgren, C
Elfving, M
Wikland, KA
Norjavaara, E
机构
[1] Gothenburg Univ, Goteborg Pediat Growth Res Ctr, Inst Hlth Women & Children, S-41685 Gothenburg, Sweden
[2] Univ Lund, Dept Pediat, S-22185 Lund, Sweden
关键词
D O I
10.1210/jc.86.7.3039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of pubertal induction in children with hypogonadism is to mimic spontaneous puberty in terms of physical and psychological development. In a clinical observation study, we induced puberty in 15 girls with hyper- or hypogonadotropic hypogonadism using low doses of transdermal estradiol patches attached only during the night and compared the estradiol concentrations obtained with those in healthy girls. Pubertal induction was started between the ages of 12.3 and 18.1 yr. A transdermal matrix patch of 17 beta -estradiol (25 mug/24 h; Evorel, Janssen Pharmaceuticals-Cilag) was cut into pieces corresponding to 3.1, 4.2, or 6.2 mug/24 h initially and attached to the buttock. After 4-14 months, the dose was increased gradually. Serum 17 beta -estradiol concentrations were measured every 2 h by RIA (detection limit, 6.0 pmol/L; 1.6 pg/mL). The results show that it is possible to mimic the spontaneous levels as well as the diurnal pattern of serum 17 beta -estradiol in early puberty, by cutting a transdermal 17 beta -estradiol matrix patch and attaching a part of it, corresponding to 0.08-0.12 pg estradiol/kg BW, to the buttock nocturnally. In most of the girls, breast development occurred within 3- 6 months of the start of treatment.
引用
收藏
页码:3039 / 3044
页数:6
相关论文
共 26 条
[1]   Treatment of late puberty [J].
Brook, CGD .
HORMONE RESEARCH, 1999, 51 :101-103
[2]   Growth hormone therapy of Turner syndrome: The impact of age of estrogen replacement on final height [J].
Chernausek, SD ;
Attie, KM ;
Cara, JF ;
Rosenfeld, RG ;
Frane, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2439-2445
[3]   TRANSDERMAL ESTRADIOL SUBSTITUTION THERAPY FOR THE INDUCTION OF PUBERTY IN FEMALE HYPOGONADISM [J].
CISTERNINO, M ;
NAHOUL, K ;
BOZZOLA, M ;
GRIGNANI, G ;
PERANI, G ;
SAMPAOLO, P ;
ROGER, M ;
SEVERI, F .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (06) :481-488
[4]   AT III CONTENT AND ANTI-THROMBIN ACTIVITY IN OESTROGEN-PROGESTOGEN AND PROGESTOGEN-ONLY TREATED WOMEN [J].
CONARD, J ;
CAZENAVE, B ;
SAMAMA, M ;
HORELLOU, MH ;
ZORN, JR ;
NEAU, C .
THROMBOSIS RESEARCH, 1980, 18 (05) :675-681
[5]  
Cutler GB, 1997, J STEROID BIOCHEM, V61, P141
[6]   BIOLOGICAL EFFECTS OF ESTRADIOL-17-BETA-IN POSTMENOPAUSAL WOMEN - ORAL VERSUS PERCUTANEOUS ADMINISTRATION [J].
DELIGNIERES, B ;
BASDEVANT, A ;
THOMAS, G ;
THALABARD, JC ;
MERCIERBODARD, C ;
CONARD, J ;
GUYENE, TT ;
MAIRON, N ;
CORVOL, P ;
GUYGRAND, B ;
MAUVAISJARVIS, P ;
SITRUKWARE, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (03) :536-541
[7]   OSTEOPENIA IN MEN WITH A HISTORY OF DELAYED PUBERTY [J].
FINKELSTEIN, JS ;
NEER, RM ;
BILLER, BMK ;
CRAWFORD, JD ;
KLIBANSKI, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :600-604
[8]  
FOREST MG, 1993, PEDIAT ENDOCRINOLOGY, P351
[10]   A PHYSIOLOGICAL MODE OF PUBERTY INDUCTION IN HYPOGONADAL GIRLS BY LOW-DOSE TRANSDERMAL 17-BETA-ESTRADIOL [J].
ILLIG, R ;
DECAMPO, C ;
LANGMURITANO, MR ;
PRADER, A ;
TORRESANI, T ;
WERDER, EA ;
WILLI, U ;
SCHENKEL, L .
EUROPEAN JOURNAL OF PEDIATRICS, 1990, 150 (02) :86-91